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Primary Isolation of Ehrlichia chaffeensis from Patients with Febrile Illnesses: 
Clinical and Molecular Characteristics 
Steven M. Standaert,1 Tina Yu,1 Margie A. Scott,1 
James E. Childs,2 Christopher D. Paddock,2 
William L. Nicholson,2 Joseph Singleton, Jr.,2 
and Martin J. Blaser1 
1Division of Infectious Diseases, Department of Medicine, 
and Department of Pathology, Vanderbilt University School 
of Medicine, and VA Medical Center, Nashville, Tennessee; 2Division 
of Viral and Rickettsial Diseases, National Center for Infectious 
Diseases, Centers for Disease Control and Prevention, 
Atlanta, Georgia 
Ehrlichia chaffeensis was sought among patients with a history of tick exposure and fever, 
and the accuracy of other diagnostic tests was compared with that of primary isolation. Among 
the 38 patients enrolled, E. chaffeensis was isolated from the blood of 7 (180Zo) and from 
cerebrospinal fluid specimens of 2 of these 7. All 7 patients also were positive by polymerase 
chain reaction (PCR) of blood, and 6 patients developed diagnostic titers of antibody to E. 
chaffeensis. The isolates were characterized by molecular analysis of the 16S rRNA gene, the 
120-kDa protein gene, and the variable-length PCR target (VLPT) of E. chaffeensis. On the 
basis of the 120-kDa and VLPT genotypes, the cerebrospinal fluid and blood isolates from 
the same patients were identical. This study demonstrates that both PCR and culture of blood 
for E. chaffeensis have high diagnostic yields. More frequent isolation of E. chaffeensis from 
patients with infection should further our understanding of the pathogenesis of this infection. 
Infection by Ehrlichia chaffeensis may be mild or may cause 
severe or fatal disease. Although human monocytotropic ehr- 
lichiosis (HME) was first recognized in 1986 [1], it was not until 
1990 that the causative organism, E. chaffeensis, was isolated 
from a military recruit with a febrile illness after a tick bite 
while at Fort Chaffee, Arkansas [2]. Only 8 other primary iso- 
lates have been reported subsequently [3-6], presumably be- 
cause of the complex growth requirements of this obligate in- 
tracellular bacterium. In contrast, successful isolation of the 
agent of human granulocytotropic ehrlichiosis (HGE), the 
other common form of human ehrlichiosis in the United States, 
has been reported in as many as one-third of patients with acute 
infection from whom isolation has been attempted [7]. 
Because isolation of E. chaffeensis from clinical specimens is 
rare, the accuracy of indirect diagnostic tests is unknown. More 
frequent isolation of this organism also is needed to further 
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define the range of clinical characteristics and the pathophys- 
iology of infection. Therefore, we sought to determine whether 
a systematic effort to culture clinical specimens from patients 
with suspected HME would result in more frequent isolations 
of E. chaffeensis. We attempted to define the accuracy of the 
currently available diagnostic techniques by use of culture of 
the organism as the reference standard for comparison. We 
further sought to characterize each isolate by molecular analysis 
of genes with known diversity [4, 5, 8, 9]. 
Methods 
Prospective enrollment. Between 15 April and 15 October 1998, 
we enrolled patients with possible tickborne infection who pre- 
sented to the 3 Vanderbilt University-affiliated hospitals. Enroll- 
ment criteria included fever (^37.50C), a history of tick bite or 
exposure, and a clinical suspicion of tickborne rickettsial infection 
sufficient to warrant doxycycline therapy. All enrolled patients were 
interviewed with a standard questionnaire, and their medical re- 
cords were reviewed. Peripheral blood smears from all patients were 
evaluated for the presence of intraleukocytic ehrlichial inclusions 
(morulae) at the time of enrollment. 
For each patient, an acute-phase serum specimen and an EDTA- 
anticoagulated whole blood specimen were collected at the time of 
presentation, and a convalescent-phase serum specimen was ob- 
tained 4-6 weeks later. Lumbar punctures were done for patients 
whose clinical condition suggested meningitis, and a 1- to 3-mL 
cerebrospinal fluid (CSF) specimen was collected for study 
purposes. 
Primary isolation ofE. chaffeensis. Blood and CSF specimens 
were transported and processed for culture immediately after col- 
lection. The EDTA-anticoagulated whole blood specimen (2-3 mL) 
was diluted with 2 v of sterile Hanks' balanced salt solution (HBSS; 
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Life Technologies Gibco BRL, Gaithersburg, MD), layered onto 
Histopaque 1083 (Sigma, St. Louis), and centrifuged at 800 g for 
20 min. The leukocyte-enriched fraction was collected and diluted 
in 10 mL of HBSS and centrifuged at 400 g for 10 min. The CSF 
specimens were diluted in 10 mL of HBSS and centrifuged at 400 
g for 10 min. The cell pellet was resuspended in 4 mL of cell culture 
medium, which was prepared as described elsewhere [5] except that 
the fetal bovine serum concentration was 6.507o. The cell suspension 
was inoculated onto a confluent layer of DH82 cells (canine per- 
itoneal macrophage; ATCC 10389) in a 25-cm2 cell culture flask 
and incubated at 370C in a 507o C02 atmosphere. The culture me- 
dium was changed at 48 h and then twice weekly thereafter for 60 
days. Cultures were monitored for infection by use of Leukostat- 
stained (Fisher Scientific, Philadelphia) cytocentrifuged prepara- 
tions at least weekly for the first 30 days and serially thereafter. 
Polymerase chain reaction (PCR). DNA extraction and nested 
PCR of the 16S rRNA gene of E. chaffeensis, the HGE agent, and 
Rickettsia rickettsii were done on all blood specimens (and CSF 
specimens when available) from enrolled patients and all primary 
isolates, as described elsewhere [10], except for the addition of an 
R. rickettsii species-specific primer (RR1F, CTAATTGGGG- 
CTTGCTCCAATTAG) of our own design. Briefly, the product 
from the first-round reaction with broad-range 16S rDNA primers, 
8F and 1448R [10], was used as the DNA template for the second 
(nested) reaction. For each specimen, 3 simultaneous second-round 
reactions were done with species-specific primers for E. chaffeensis, 
the HGE agent, and R. rickettsii in pairwise combination with a 
primer with enhanced specificity for Ehrlichia species, GA1UR [10]. 
Both positive- and negative-control specimens were tested simul- 
taneously with each reaction. The positive-control DNA specimens 
were obtained from culture-derived E. chaffeensis, the HGE agent 
(provided by J. S. Dumler, Johns Hopkins University Hospital, 
Baltimore), and R. rickettsii (provided by D. H. Walker, University 
of Texas Medical Branch, Galveston). The negative-control spec- 
imens were sterile water, DNA obtained from the blood of an 
uninfected person (S.M.S.), and uninfected DH82 cells. For nu- 
cleotide sequencing of the 16S rRNA gene from the patients with 
PCR evidence of E. chaffeensis infection and the respective primary 
isolates, the second-round reaction was done with primers 15F 
(ATCATGGCTCAGAACGAACG) and 208R (CGTAGGCT- 
CATCTAATAGCG) to amplify a variable region of the gene useful 
for species identification. The sequences of these products were 
compared with the published sequences of the previous known 
isolates of E. chaffeensis (GenBank: Arkansas, M73222; Sapulpa, 
U60476; 91HE17, U23503; Jax, U86664; St. Vincent, U86665). 
To further characterize each E. chaffeensis isolate, PCR ampli- 
fication of the 120-kDa protein gene and the variable-length PCR 
target (VLPT) gene were done on all isolates, as well as the original 
blood or CSF clinical specimen from which the isolate was ob- 
tained. Both genes contain several tandem repeat units (240 bp in 
the 120-kDa protein gene and 90 bp in the VLPT gene), which 
have been reported to vary between strains [5, 6, 8, 9]. All reactions 
were done as described elsewhere [5]; primers Fl and R2 were used 
for the 120-kDa protein gene and FB3 and FB5 for the VLPT gene. 
All PCR reagents were supplied by Qiagen (Chatsworth, CA), and 
reactions were done in a DNA thermal cycler (Perkin-Elmer, Nor- 
walk, CT). 
Serologic studies. All serum specimens from enrolled patients 
were examined at the Centers for Disease Control and Prevention 
in a blinded fashion. An indirect immunofluorescence assay was 
used to identify antibodies reactive with E. chaffeensis, the HGE 
agent, and R. rickettsii, as described elsewhere [2]. 
Case definitions. A confirmed case of HME, HGE, or Rocky 
Mountain spotted fever (RMSF) was defined as occurring in any 
patient whose blood specimen was positive by PCR testing with 
species-specific primers for 16S rDNA or whose serum specimens 
revealed a ^4-fold change in antibody titer for E. chaffeensis, the 
HGE agent, or R. rickettsii, respectively [11]. A culture-confirmed 
case of HME was defined as occurring in any patient whose blood 
specimen yielded a primary isolate of E. chaffeensis. 
Statistical analysis. Significance tests were done with the 
Mann-Whitney U test for continuous variables and Fisher's exact 
test for dichotomous variables performed by use of Epi Info [12]. 
Results 
Confirmed cases of HME. A total of 38 patients were en- 
rolled during the 6-month study period. Of these, E. chaffeensis 
was isolated from blood cultures from 7 patients (1807o), who 
thus were defined as having culture-confirmed cases of HME 
(table 1). We have designated these 7 E. chaffeensis isolates as 
Vanderbilt 1-7 (Vl-7), on the basis of the order in which the 
patients presented during the study. E. chaffeensis also was 
isolated from the CSF specimens of 2 of these patients (V4C 
and V6C). 
Assessment of E. chaffeensis diagnostics. Each of the 7 
patients with culture-confirmed HME also was positive by E. 
chaffeensis-spGcilic PCR testing of whole blood (table 2). Al- 
though the true clinical specificity of the PCR is not known, 
these data suggest that it is very high, because it was not positive 
for any of the 31 culture-negative patients. Of the 7 patients 
with confirmed HME, examination of the peripheral blood 
smears revealed characteristic ehrlichial morulae in 2 (2907o). 
Acute and convalescent sera were available for 34 (8907o) of 
the enrolled patients. Six of the 7 patients with confirmed HME 
Table 1. Diagnostic findings for 38 enrolled study patients with febrile 
illness and history of tick exposure. 
Total no. of 
Culture PCR Serology subjects in whom 
Organism (n = 38) (n = 38) (n = 34) pathogen identified 
Ehrlichia chaffeensis T t 6C 7 
HGE agent ND 0 0 0 
Rickettsia rickettsii ND 3 6d 6 
Negative 31 28 22c ? 
NOTE. Data (except for negative results) are no. of patients positive by 
diagnostic test. HGE, human granulocytic ehrlichiosis; ND, not done; PCR, 
polymerase chain reaction. a E. chaffeensis was isolated from both blood and cerebrospinal fluid of 2 
patients. 
PCR with E. chaffeensis-sipQcific primers was positive in both blood and CSF 
of 1 patient. 
c One patient (VI) with E. chaffeensis infection did not have detectable anti- 
body in either acute or convalescent serum specimen and is included with other 
21 serologically negative patients. d d Three of these patients also were PCR-positive for R. rickettsii. 
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Table 2. Results of nonculture methods for identification of Ehrlichia 
chaffeensis in 7 patients with confirmed infection. 
Serology 
Peripheral blood Acute Convalescent 
Days after Days after 
Patient Morulaea PCRb Titer symptom onset Titer symptom onset 
VI - + <32 <1 <32 48 
V2 - 4- <32 6 4096 43 
V3 + + 4096 14 2048 54 
V4 - + 1024 14 512 83 
V5 + + <32 3 4096 43 
V6 - + <32 3 4096 50 
V7 - + <32 4 1024 53 
a Presence of morulae on examination of Wright-stained smear of peripheral 
blood. - , negative; 4- , positive. 
Polymerase chain reaction of whole blood specimen. 
developed diagnostic antibody titers within 14-43 days of the 
onset of illness (range of reciprocal titers, 512-^096; table 2). 
One patient (VI) with confirmed HME who had received dox- 
ycycline therapy during the first 12 h after the onset of fever 
never developed diagnostic serum titers of antibody to E. 
chaffeensis. 
In addition to the cases of HME, there were 6 (1607o) con- 
firmed cases of RMSF and no cases of HGE (table 1). Among 
the remaining 25 patients, there was no evidence of infection 
with E. chaffeensis, the HGE agent, or R. rickettsii by any 
modality; only the 21 patients for whom both acute and con- 
valescent specimens were available were used for subsequent 
comparisons. 
Clinical and epidemiologic features of HME cases. All cases 
of HME occurred between late April and the first week of 
August, whereas the cases of RMSF extended to late September 
(figure 1). The patients with HME originated from four counties 
in Tennessee and a single county in Kentucky, and there was 
no geographic clustering of cases. There were no significant 
differences in demographic characteristics between patients 
with HME, patients with RMSF, and those without either in- 
fection, although 12 (9207o) of the 13 patients with either HME 
or RMSF were male and 10 (7707o) required hospitalization 
(table 3). A nonspecific, fleeting maculopapular rash on the 
face and neck occurred in 2 patients with HME (2307o), whereas 
a typical petechial rash occurred in 4 patients with RMSF 
(6707o). A nonspecific maculopapular rash occurred in 6 patients 
for whom no infecting agent was identified. The only laboratory 
findings that were significantly different between patients with 
HME and those without either HME or RMSF were the degree 
of thrombocytopenia and the proportion with elevated serum 
aspartate aminotransferase. However, 7107o of patients with 
HME had leukopenia and none had an abnormally elevated 
white blood cell count. 
Of the 21 patients without either HME or RMSF, a definitive 
diagnosis was determined for only 2; 1 patient had Staphylo- 
coccus aureus bacteremia and the other patient had AIDS and 
acute hepatitis A virus infection. There were no deaths among 
the patients enrolled in the study. 
Characteristics of the primary isolation of E. chaffeensis. 
For the 9 samples that yielded E. chaffeensis, the median time 
between collecting the blood and CSF specimens from patients 
and inoculating the leukocyte-enriched fraction into cell culture 
was 3 h (range, 1-18). This interval did not differ from that 
for the 31 culture-negative patients (median, 3 h; range, 1-10). 
Primary isolation of ehrlichiae from the blood specimens, as 
evidenced by visualization of morulae in the cytoplasm of 
DH82 cells, occurred between 2 and 12 days (median, 11) after 
inoculation. There was no significant relationship between the 
rapidity of inoculation and either the success or rapidity of 
primary isolation in cell culture (data not shown). Of the 2 
isolates from CSF, 1, from a patient (V4) with obvious men- 
ingitis (310 white blood cells/mm3), was seen 16 days after cell 
culture inoculation. In contrast, in patient V6, in whom only 
a single CSF white blood cell and no red blood cells were 
present, E. chaffeensis was isolated 50 days after cell culture 
inoculation. 
Molecular characteristics ofE. chaffeensis isolates. Nested 
PCR with the E. chaffeensis-specific primers HE1 and GA1UR 
and DNA extracts of the 9 isolates from all 7 patients yielded 
the characteristic 389-bp 16S rRNA gene product (data not 
shown). The nucleotide sequence of the variable 190-bp region 
of the 16S rRNA gene (as determined by use of primers 15F 
and 208R) from each patient's blood specimen and the 7 isolates 
was identical to the GenBank sequence for the previous E. 
chaffeensis isolates. 
PCR amplification of the 120-kDa protein gene and the 
VLPT gene produced amplicons varying from ~1000 to 1500 
bp and 369 to 539 bp, respectively, from the 9 isolates (table 
4). The number of repeat units, as inferred from the size of 
these products, ranged from 2 to 4 repeats for the 120-kDa 
protein gene and 3 to 5 repeats for the VLPT gene (table 4). 
Nucleotide sequencing of the VLPT gene PCR products con- 
firmed these findings (data not shown). Because of the large 
size of the 120-kDa gene, confirmatory nucleotide sequencing 
was not done. On the basis of the number of repeats of these 
2 genes, 5 distinct molecular patterns were observed among the 
9 isolates. For each patient, the PCR product obtained directly 
from the blood had the same apparent migration as the product 
obtained from the corresponding E. chaffeensis isolate (figure 
2); the product from each of the CSF isolates also was identical 
to that of the corresponding blood isolate. 
Discussion 
Primary isolation of E. chaffeensis from infected patients has 
been difficult. Attempts to isolate the organism have been lim- 
ited by the requirement for antibiotic-free cell culture techniques 
and a concern for the potential risk of laboratory-acquired 
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A. americanum 
life-cycle 
Month of Presentation 
Adults and Nymphs 
Larvae 
Figure 1. Distribution of febrile tickborne illness among 38 enrolled patients from 15 April to 15 October 1998, Nashville. Seasonal changes 
of life-cycle stages of Amblyomma mericanum, likely tick vector for Ehrlichia chaffeensis, are indicated by arrows below graph. E. chaffeensis is 
not believed to be passed transovarially within tick, and therefore only adults and nymphs are potentially infectious. HME, human monocytotropic 
ehrlichiosis; RMSF, Rocky Mountain spotted fever. 
infections, as has been reported with R. rickettsii [13]. Despite 
numerous attempts, only 9 primary isolates have been described 
in the previous 8 years [2-6]. In this study, E. chaffeensis was 
isolated from blood specimens from 7 patients in one locale 
over a 6-month period; isolation was 10007o sensitive, on the 
basis of both PCR and serologic criteria. The time to culture 
positivity was substantially shorter in this study (median, 11 
days) than reported for the other E. chaffeensis isolates (median, 
20 days) [2-5]. This rapidity likely was due to the proximity of 
our laboratory to the patients, resulting in brief (median, 3-h) 
intervals until specimen inoculation in cell culture. Although 
isolation of E. chaffeensis was not more likely when culture 
inoculation occurred early within the 18-h range, the preino- 
culation time likely was much longer for previous E. chaffeensis 
isolation attempts, given the inherent delays in transporting 
clinical specimens to research centers. The proximity of infected 
patients to a specialized research laboratory probably also con- 
tributed to the first successful isolation of the HGE agent [14]. 
The lower concentration (6.507o) of fetal bovine serum used in 
our cell culture media compared with previous efforts 
(8.807o-1207o) [2-6] may have contributed to E. chaffeensis iso- 
lation, as suggested elsewhere [3]. 
Despite the high sensitivity of primary isolation of E. chaf- 
feensis from clinical specimens, the required technical expertise 
and prolonged incubation time may curtail its widespread di- 
agnostic use. However, we and others [15, 16] have found PCR 
to be both rapid and accurate for diagnosing E. chaffeensis 
infections and, thus, useful in initial patient management. PCR- 
based techniques are increasingly becoming standardized and 
clinically available. In contrast, the sensitivity of early serologic 
testing for E. chaffeensis infection is poor, because only 2 (2907o) 
of the 7 patients with confirmed HME in our series had de- 
tectable antibody levels on initial presentation, and both pa- 
tients already had been ill for 14 days. Despite the rapidity and 
increased sensitivity of PCR testing, empirical therapy with 
doxycycline should be administered immediately without wait- 
ing for the results of diagnostic testing, because any delay in 
therapy can lead to increased morbidity and mortality [17]. 
The improved sensitivity of the nested PCR protocol we used 
may be offset by an increased risk of contamination, because 
specimens must be handled more frequently. Nonetheless, we 
chose to use this technique during our study for 2 reasons. 
First, the same 16S rDNA amplicon from the first reaction can 
be used as the template for subsequent reactions to test for 
several different organisms simultaneously. In addition, we have 
found that a nested reaction is required to detect R. rickettsii 
from blood specimens, because the number of organisms in 
peripheral blood is so few. As with any laboratory test, si- 
multaneous reactions with adequate positive and negative con- 
trol specimens are essential. Laboratories that handle a large 
number of clinical specimens may find that a nested protocol 
is too problematic to be used for routine diagnostic purposes. 
However, our data indicate that this approach is feasible, es- 
pecially when the PCR amplicon identity is confirmed by nu- 
cleotide sequencing. 
All patients with E. chaffeensis infection became ill between 
late April and the first week of August (figure 1). A similar 
seasonal distribution of HME in Tennessee has been noted 
earlier [15] and may reflect the seasonal activities of the tick 
vector, Amblyomma americanum [18, 19]. E. chaffeensis is not 
believed to be passed transovarially within the tick, and there- 
fore only the adults and nymphs are potentially infectious. 
Questing A. americanum adults and nymphs are present from 
early spring to midsummer in Tennessee, but beyond August 
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Table 3. Demographic characteristics and laboratory results for 34 study patients 
with history of tick exposure by tickborne illness. 
Human 
Demographic or monocytic Rocky Mountain No agent 
clinical characteristic ehrlichiosis spotted fever identified 
or laboratory value (n = 7) (n = 6) (? = 21) 
Age, years 36 (10-57) 33 (0.6-69) 37 (7-72) 
No. male 6 6 11 
No. hospitalized 5 5 12 
No. with reported tick bite 4 2 7 
No. with rash 2 4 6 
White blood cell count, 
cells X 103/mm3 2.1 (1.4-7.5) 10.2 (1.4-16.8) 5.1 (1.9-11.5) 
No. with leukopenia (<4.5 X 103 
white blood cells/mm3) 5 1 9 
Hematocrit, % 37 (31-45) 40 (32^13) 41 (29-48) 
No. with anemia (for age and sex) 4 2 8 
Platelet count, cells X 103/mm3 75 (37-206)a 159 (21-367) 167 (62-327) 
No. with thrombocytopenia 
(<150 X 103 platelets/mm3) 6 3 10 
Serum aspartate 
aminotransferase l vel, IU 155 (52-281)b 54 (17-167) 36 (17-2173) 
No. with abnormal serum 
aspartate aminotransferase 
value (>40IU) 7a 3 5C 
Bilirubin level, mg/dL 2.3 (0.7-5.3) 1.0 (0.4-3.1) 0.7 (0.2-6.5) 
No. with abnormal bilirubin 
value (>1.0 mg/dL) 4 2 4C 
NOTE. Data with parentheses are median (range). Only acute serum specimens were ob- 
tained from 4 patients, and they were excluded from original 38 patients. All 4 were negative 
by culture and polymerase chain reaction for organisms of interest. 
a P<.05 vs. patients with no agent identified. 
bn P*c.05 vs. patients with Rocky Mountain spotted fever. 
c Determined for only 11 patients. 
only larval ticks can be found. In contrast, the adult stage of 
Dermacentor variabilis, the predominant vector of R. rickettsii 
in Tennessee, is present late into the fall [20], which is consistent 
with our identification of patients with RMSF in September. 
Meningitis has been increasingly recognized as a feature of 
E. chaffeensis infection [21, 22]. Although E. chaffeensis has 
been detected in CSF by PCR [23], we now report its isolation. 
Lumbar puncture was done for only 2 of the 7 patients with 
E. chaffeensis infection, and a primary isolate identical to the 
blood isolate was recovered from both specimens. Since 1 of 
these patients (V6) had no laboratory evidence of meningitis, 
the frequency of E. chaffeensis invasion of the CSF during acute 
infection and then its elimination, either by antibiotic therapy 
or the host immune response, is unknown. The findings in 
patient V6, that PCR yielded negative results and culture re- 
quired 50 days, suggest that the actual number of Ehrlichiae 
in the CSF was small. Although contamination of the CSF 
with the blood isolate during the lumbar puncture may have 
occurred, we believe this to be unlikely, because no red blood 
cells were detected in the CSF specimen from this patient. 
E. chaffeensis isolates are polymorphic in the number of re- 
petitive sequences within the genes encoding the 120-kDa sur- 
face protein and VLPT [4-6, 8, 9], and the isolates we obtained 
illustrate this phenomenon. Isolate V5 had only 2 repeat units 
in the 120-kDa gene, a novel finding (table 4). On a practical 
level, these studies are useful by indicating that neither the 
initial diagnostic PCR results nor the isolated organisms were 
falsely positive as a result of contamination with laboratory 
strains of E. chaffeensis. From a biologic and epidemiologic 
perspective, further study of the genetic polymorphisms of the 
VLPT and the 120-kDa protein genes would be interesting to 
determine if they can be correlated with pathogenicity or geo- 
graphic distribution of different strains. Several pathogenic or- 
ganisms, including Rickettsia species, have genes with repeat 
Table 4. Size variation in 120-kDa protein gene and variable-length 
polymerase chain reaction (PCR) target (VLPT) gene in 18 known 
Ehrlichia chaffeensis isolates. 
No. of repeatsa New 
Previous isolate [ref.] isolate 120-kDa protein VLPT 
Wakulla [6] 4 6 
91HE17[3] V7 4 5 
Arkansas, Jax, Liberty 
[2, 5, 6] VI, V4b 4 4 
St. Vincent, Sapulpa, 
West Paces [4, 5] V3 3 3 
Osceola [6] V2, V6b 3 4 
V5 2 4 
a As determined by nucleotide sequencing for VLPT and from size of PCR 
product for 120-kDa gene (figure 2). 
For individual patient, cerebrospinal fluid and blood isolates showed identical 
patterns by PCR. 
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Figure 2. Variation of no. of tandem repetitive sequences in 120-kDa protein gene and variable length polymerase chain reaction (PCR) target 
(VLPT) identified by agarose gel electrophoresis of PCR products of clinical specimens (lanes B, whole blood; lanes C, cerebrospinal fluid [CSF]) 
from patients V7, V4, and V3 and corresponding Ehrlichia chaffeensis isolates (lanes I) from culture in DH82 cells. Patient V4 had meningitis, 
and isolate (Ic) was obtained from CSF. Both genes encode variable number of tandem repeats that vary between strains. Arrows represent no. 
of repeat units observed for 120-kDa protein gene (4 repeats -^ 1500 bp, 3 repeats -- 1250 bp) and VLPT gene (5 repeats - 549 bp, 4 
repeats ^  459 bp, 3 repeats = 369 bp). Amplicon sizes of clinical blood and CSF specimens are all identical to that of corresponding E. chaffeensis 
culture isolate from that specimen, indicating that isolated strain was detected by direct PCR of clinical specimens. Nos. of repeat units noted 
for genes are independent of each other: for example, amplicon sizes for 120-kDa protein gene are identical in all specimens from patient V7 and 
V4, but sizes of VLPT amplicons are different. Lane L, molecular size standard ladder; lane N, negative control (uninfected DH82 cells). 
domains that encode for surface proteins involved in antigenic 
variation and possibly in adherence to host cells [24-27]. We 
and others have found no geographic clustering of E. chaf- 
feensis strains on the basis of the genotypes examined, although 
the number of samples examined is low [5, 6, 9]. In addition, 
none of the patterns observed among the 7 new isolates was 
predictive of a particular clinical outcome. Further analysis of 
these potential relationships may be more revealing as we in- 
crease the number of isolates from infected patients. 
One-third of the patients enrolled in this study were found 
to have a tickborne rickettsial infection, either HME or RMSF. 
Equally provocative, however, is the cause of illness in the 19 
patients without an identifiable rickettsial or other known in- 
fection. All recovered from their illness without consequence, 
and several appeared to respond to doxycycline therapy. Yet- 
to-be-identified organisms that infect humans could be con- 
tributing to this group of undefined, apparently doxycycline- 
responsive febrile illnesses [28]. The development of molecular 
tools, such as broad-range PCR primers, may permit identifi- 
cation of novel rickettsial (including Ehrlichia) species in 
humans. 
This study represents the first systematic effort to isolate E. 
chaffeensis from patients with febrile illness following tick ex- 
posure. In contrast to previous investigations, we were able to 
isolate the organism from each patient in our study who had 
any evidence of E. chaffeensis infection. Because the diagnostic 
accuracy of the other available modalities (detection of mor- 
ulae, PCR, and serology) has not been defined, the ability to 
readily culture the organism now can serve as a reference stan- 
dard for comparison. Although the prolonged time for culture 
(median, 11 days) precludes its application for rapid diagnosis, 
examination of peripheral blood by means of PCR and staining 
may be clinically useful. Finally, our demonstration of the feas- 
ibility of culturing E. chaffeensis directly from patient blood 
and CSF specimens should improve understanding of the phy- 
logeny of this organism and the epidemiology and pathogenesis 
of infection. 
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